Evidence map›Paper›PMID 35206888›Full record

ArticleHealthcare (Basel, Switzerland)2022

Analysis of Healthcare Expenditures in Bulgaria.

Zornitsa Mitkova, Miglena Doneva, Nikolay Gerasimov, Konstantin Tachkov, Maria Dimitrova, Maria Kamusheva, Guenka Petrova

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zornitsa MitkovaDepartment of Organization and Economy of Pharmacy, Faculty of Pharmacy, Medical University-Sofia, 1000 Sofia, Bulgaria.ORCID 0000-0003-0782-200X
Miglena DonevaDepartment of Organization and Economy of Pharmacy, Faculty of Pharmacy, Medical University-Sofia, 1000 Sofia, Bulgaria.
Nikolay GerasimovMedical College, Trakia University, 6000 Stara Zagora, Bulgaria.
Konstantin TachkovDepartment of Organization and Economy of Pharmacy, Faculty of Pharmacy, Medical University-Sofia, 1000 Sofia, Bulgaria.ORCID 0000-0002-3961-7556
Maria DimitrovaDepartment of Organization and Economy of Pharmacy, Faculty of Pharmacy, Medical University-Sofia, 1000 Sofia, Bulgaria.
Maria KamushevaDepartment of Organization and Economy of Pharmacy, Faculty of Pharmacy, Medical University-Sofia, 1000 Sofia, Bulgaria.
Guenka PetrovaDepartment of Organization and Economy of Pharmacy, Faculty of Pharmacy, Medical University-Sofia, 1000 Sofia, Bulgaria.
Medical University of Sofia · BGTrakia University · BG

Funding

National scientific program "Electronic healthcare in Bulgaria ("E-health") 01-200/16.11.2018
6 · The paper itself

Abstract

The growth of public expenditure worldwide has set the priority on assessment of trends and establishment of factors which generate the most significant public costs. The goal of the current study is to review the tendencies in public healthcare expenditures in Bulgaria and to analyze the influence of the demographic, economic, and healthcare system capacity indicators on expenditures dynamics. A retrospective, top-down, financial analysis of the healthcare system expenditures was performed. Datasets of the National Statistical Institute (NSI), National Health Insurance Fund (NHIF), and National Center of Public Health and Analysis (NCPHA) were retrospectively reviewed from2014-2019 to collect the information in absolute units of healthcare expenditures, healthcare system performance, demographics, and economic indicators. The research showed that increasing GDP led to higher healthcare costs, and it was the main factor affecting the cost growth in Bulgaria. The number of hospitalized patients and citizens in retirement age remained constant, confirming that their impact on healthcare costs was negligible. In conclusion, the population aging, average life expectancy, patient morbidity, and hospitalization rate altogether impacted healthcare costs mainly due to the multimorbidity of older people and the rising need for outpatient hospital services and medications.

Indexed as

demographicseconomic indicatorshealthcare system performancepublic expenditure

Identifiers

PMID35206888
PMCPMC8872167
OpenAlexW4210804098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.